RALEIGH, N.C., Dec. 4 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces the opening of a Munich office, the company's third office in Germany. PRA's office in Mannheim, Germany, established its initial European presence more than 27 years ago. Since that time, PRA has expanded to numerous locations throughout Western Europe, Eastern Europe and several other global regions.
The new office in Munich provides proximity to major pharmaceutical companies operating in and around that city, as well as access to the area's skilled workforce. Located at Atrium, Riesstrasse 29, the new space will initially house over a dozen employees, with future expansions planned for more than 20 employees in the next 12 months and a total of more than 50 within five years.
PRA has conducted clinical trials in more than 60 countries during its more than 30-year history. Operating in Europe since 1981, PRA has executed over 1,000 studies through its 15 European offices. PRA's European capabilities include:
- Clinical operations staff providing coverage to 38 European countries for Phase II through Phase IV studies; - Two 70-bed Phase I units; - An innovative "virtual Phase I" model in central Europe; and - A world class bioanalytical laboratory.
"We are extremely pleased to broaden our coverage with an additional office in Munich," commented Susan Stansfield, Executive VP of Product Registration for Europe, Africa and Asia-Pacific. "The location in Munich complements our existing offices in Mannheim and Berlin and enables us to more easily cover a wider range of Germany and the surrounding countries."
About PRA International
PRA International is a global Clinical Research Organization providing
services through all phases of clinical development. Although we specialize in
Oncology, CNS, Respiratory/Allergy, Cardiov
|SOURCE PRA International|
Copyright©2008 PR Newswire.
All rights reserved